Molecular Regulation of Melanin Formation: Melanosome Transporter Proteins

The Pigmentary System: Physiology and Pathophysiology: Second Edition

Volumn , Issue , 2007, Pages 230-241

  Brilliant, Murray H ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Eumelanin; Melanosome transporter proteins; Membrane associated transport protein; Oculocutaneous albinism; P protein

Indexed keywords

EID: 84889623753     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987100.ch12     Document Type: Chapter

References (145)

1. Akahoshi, K., K. Fukai, A. Kato, S. Kimiya, T. Kubota, and R. A. Spritz. Duplication of 15q11.2-q14, including the P gene, in a woman with generalized skin hyperpigmentation. Am. J. Med. Genet. 104:299-302, 2001.
2. Akahoshi, K., R. A. Spritz, K. Fukai, N. Mitsui, K. Matsushima, and H. Ohashi. Mosaic supernumerary inv dup(15) chromosome with four copies of the P gene in a boy with pigmentary dysplasia. Am. J. Med. Genet. 126 A: 290-292, 2004.
3. Akey, J. M., H. Wang, M. Xiong, H. Wu, W. Liu, M.D. Shriver, and L. Jin. Interaction between the melanocortin-1 receptor and P genes contributes to inter-individual variation in skin pigmentation phenotypes in a Tibetan population. Hum. Genet. 108:516-520, 2001.
4. Al-Awqati, Q. Chloride channels of intracellular organelles. Curr. Opin. Cell Biol. 7:504-508, 1995.
5. Ancans, J., and A. J. Thody. Activation of melanogenesis by vacuolar type H(+)-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells. FEBS Lett. 478:57-60, 2000.
6. Ancans, J., D. J. Tobin, M. J. Hoogduijn, N. P. Smit, K. Wakamatsu, and A. J. Thody. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells. Exp. Cell Res. 268:26-35, 2001.
7. Ancans, J., N. Flanagan, M. J. Hoogduijn, and A. J. Thody. P-locus is a target for the melanogenic effects of MC-1R signaling: a possible control point for facultative pigmentation. Ann. N. Y. Acad. Sci. 994:373-377, 2003.
8. Baxter, L. L., and W. J. Pavan. The oculocutaneous albinism type IV gene Matp is a new marker of pigment cell precursors during mouse embryonic development. Mech. Dev. 116:209-212, 2002.
9. Bhatnagar, V., S. Anjaiah, A. Puri, N. Puri, B. N. A. Darshanam, and A. Ramaiah. pH of melanosomes of B16 murine melanoma is acidic: Its physiological importance in the regulation of melanin biosynthesis. Arch. Biochem. Biophys. 307:183-192, 1993.
10. Bray, G. A., W. T. Dahms, R. S. Swerdloff, R. H. Fiser, R. L. Atkinson, and R. E. Carrel. The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine 62:59-80, 1983.
11. Brilliant, M. H. The mouse pink-eyed dilution locus: a model for aspects of Prader-Willi syndrome, Angelman syndrome, and a form of hypomelanosis of Ito. Mamm. Genome 3:187-191, 1992.
12. Brilliant, M. H. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Res. 14:86-93, 2001.
13. Brilliant, M. H., Y. Gondo, and E. M. Eicher. Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning. Science 252:566-569, 1991.
14. Brilliant, M. H., A. Ching, Y. Nakatsu, and E. M. Eicher. The original pink-eyed dilution mutation (p) arose in Asiatic mice: implications for the H4 minor histocompatibility antigen, Myod1 regulation and the origin of inbred strains. Genetics 138:203-211, 1994 a.
15. Brilliant, M. H., R. A. King, U. Francke, S. Schuffenhauer, T. Meitinger, J. M. Gardner, D. Durham-Pierre, and Y. Nakatsu. The mouse pink-eyed dilution gene: association with hypopigmentation in Prader-Willi and Angelman syndromes and with human OCA2. Pigment Cell Res. 7:398-402, 1994 b.
16. Brilliant, M. H., R. W. Williams, B. C. Holdener, and J. M. Angel. Mouse chromosome 7. Mamm. Genome 6:S135-S150, 1996.
17. Brumbaugh, J. A., and K. W. Lee. The gene action and function of two dopa oxidase positive melanocyte mutants of the fowl. Genetics 81:333-347, 1975.
18. Butler, M. G. Hypopigmentation, a common feature of Prader-Willi syndrome. Am. J. Hum. Genet. 45:140-146, 1989.
19. Chen, K., P. Manga, and S. J. Orlow. Pink-eyed dilution protein controls the processing of tyrosinase. Mol. Biol. Cell 13:1953-1964, 2002.
20. Chiu, E., M. L. Lamoreux, and S. J. Orlow. Postnatal ocular expression of tyrosinase and related proteins: disruption by the pink-eyed unstable (pun) mutation. Exp. Eye Res. 57:301-305, 1993.
21. Christian, S. L., W. P. Robinson, B. Huang, A. Mutirangura, M. R. Line, M. Nakao, U. Surti, A. Chakravarti, and D. H Ledbetter. Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients. Am. J. Hum. Genet. 57:40-48, 1995.
22. Clayton-Smith, J. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am. J. Med. Genet. 46:12-15, 1993.
23. Coleman, D. L. Effect of genic substitution on the incorporation of tyrosine into the melanin of mouse skin. Arch. Biochem. Biophys. 96:562-568, 1962.
24. Cooksey, C. J., P. J. Garratt, E. J. Land, S. Pavel, C. A. Ramsden, P. A. Riley, and N. P. Smit. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J. Biol. Chem. 272:26226-26235, 1997.
25. Costin, G. E., J. C. Valencia, W. D. Vieira, M. L. Lamoreux, and V. J. Hearing. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4. J. Cell Sci. 116:3203-3212, 2003.
26. Creel, D. J., C. M. Bendel, G. L. Weisner, J. D. Wirtschafter, D. C. Arthur, and R. A. King. Abnormalities of the central visual pathways in Prader-Willi syndrome associated with hypopigmentation. N. Engl. J. Med. 314:1606-1609, 1986.
27. Culiat, C. T., L. Stubbs, R. D. Nicholls, C. S. Montgomery, L. B. Russell, D. K. Johnson, and E. M. Rinchik. Concordance between isolated cleft palate in mice and alterations within a region including the gene encoding the beta 3 subunit of the type A gamma-amino-butyric acid receptor. Proc. Natl. Acad. Sci. USA 90:5105-5109, 1993.
28. Culiat, C. T., L. J. Stubbs, C. S. Montgomery, L. B. Russell, and E. M. Rinchik. Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice. Proc. Natl. Acad. Sci. USA 91:2815-2818, 1994.
29. Dautry-Varsat, A., A. Ciechanover, and H. F. Lodish. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 80:2258-2262, 1983.
30. Davisson M. T., T. H. Roderick, E. C. Akeson, N. L. Hawes, and H. O. Sweet. The hairy ears (Eh) mutation is closely associated with a chromosomal rearrangement in mouse chromosome 15. Genet. Res. 56:167-178, 1990.
31. Dickie, M. M. Report. Mouse Newslett. 30:30, 1964.
32. Dell'Angelica, E. C., C. Mullins, S. Caplan, and J. S. Bonifacino. Lysosome-related organelles. FASEB J. 14:1265-1278, 2000.
33. Devi, C. C., R. K. Tripathi, and A. Ramaiah. pH-dependent interconvertible allosteric forms of murine melanoma tyrosinase. Physiological implications. Eur. J. Biochem. 166:705-711, 1987.
34. Donatien, P. D., and S. J. Orlow. Interaction of melanosomal proteins with melanin. Eur. J. Biochem. 232:159-164, 1995.
35. Du, J., and D. E. Fisher. Identification of Aim-1 as the underwhite mouse mutant and its transcriptional regulation by MITF. J. Biol. Chem. 277:402-406, 2002.
36. Duffy, D. L., N. F. Box, W. Chen, J. S. Palmer, G. W. Montgomery, M. R. James, N. K. Hayward, N. G. Martin, and R. A. Sturm. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum. Mol. Genet. 13:447-461, 2004.
37. Durham-Pierre, D., J. M. Gardner, Y. Nakatsu, R. A. King, U. Francke, A. Ching, R. Aquaron, V. del Marmol, and M. H. Brilliant. African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism. Nature Genet. 7:176-179, 1994.
38. Durham-Pierre, D., R. A. King, and M. H. Brilliant. Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African-Americans. Hum. Mutat. 7:370-373, 1996.
39. Eiberg, H., and J. Mohr. Assignment of genes coding for brown eye colour (BEY2) and brown hair colour (HCL3) on chromosome 15q. Eur. J. Hum. Genet. 4:237-241, 1996.
40. Fernandez, A., C. Castellanos, C. Rodriguez, J. L. Noguera, A. Sanchez, and C. Ovilo. Physical and linkage mapping of the porcine pink-eye dilution gene (OCA2). Anim. Genet. 33:392-394, 2002.
41. Francis E., N. Wang, H. Parag, R. Halaban, and D. N. Hebert. Tyrosinase maturation and oligomerization in the endoplasmic reticulum require a melanocyte-specific factor. J. Biol. Chem. 278:25607-25617, 2003.
42. Fridman, C., N. Hosomi, M. C. Varela, A. H. Souza, K. Fukai, and C. P. Koiffmann. Angelman syndrome associated with oculocutaneous albinism due to an intragenic deletion of the P gene. Am. J. Med. Genet. 119 A: 180-183, 2003.
43. Frudakis, T., M. Thomas, Z. Gaskin, K. Venkateswarlu, K. S. Chandra, S. Ginjupalli, S. Gunturi, S. Natrajan, V. K. Ponnuswamy, and K. N. Ponnuswamy. Sequences associated with human iris pigmentation. Genetics 165:2071-2083, 2003.
44. Fryburg, J. S., W. R. Breg, and V. Lindgren. Diagnosis of Angelman syndrome in infants. Am. J. Med. Genet. 38:58-64, 1991.
45. Fukamachi, S., A. Shimada, and A. Shima. Mutations in the gene encoding B, a novel transporter protein, reduce melanin content in medaka. Nature Genet. 28:381-385, 2001.
46. Fukamachi, S., S. Asakawa, Y. Wakamatsu, N. Shimizu, H. Mitani, and A. Shima. Conserved function of medaka pink-eyed dilution in melanin synthesis and its divergent transcriptional regulation in gonads among vertebrates. Genetics 168:1519-1527, 2004.
47. Fuller, B. B., D. T. Spaulding, and D. R. Smith. Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. Exp. Cell Res. 262:197-208, 2001.
48. Gahl, W. A., B. Potterf, D. Durham-Pierre, M. H. Brilliant, and V. J. Hearing. Melanosomal tyrosine transport in normal and pink-eyed dilution murine melanocytes. Pigment Cell Res. 8:229-233, 1995.
49. Gardner, J. M., Y. Nakatsu, Y. Gondo, S. Lee, M. F. Lyon, R. A. King, and M. H. Brilliant. The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science 257:1121-1124, 1992.
50. Gomez-Angelats, M., M. Lopez-Fontanals, A. Felipe, F. J. Casado, and M. Pastor-Anglada. Cytoskeletal-dependent activation of system A for neutral amino acid transport in osmotically stressed mammalian cells: a role for system A in the intracellular accumulation of osmolytes. J. Cell Physiol. 173:343-350, 1997.
51. Gondo, Y., J. M. Gardner, Y. Nakatsu, D. Durham-Pierre, S. A. Deveau, C. Kuper, and M. H. Brilliant. High-frequency genetic reversion mediated by a DNA duplication: the mouse pink-eyed unstable mutation. Proc. Natl. Acad. Sci. USA 90:297-301, 1993.
52. Hagiwara, N., S. E. Klewer, R. A. Samson, D. T. Erickson, M. F. Lyon, and M. H. Brilliant. Sox6 is a candidate gene for p100H myopathy, heart block, and sudden neonatal death. Proc. Natl. Acad. Sci. USA 97:4180-4185, 2000.
53. Halaban, R., R. S. Patton, E. Cheng, S. Svedine, E. S. Trombetta, M. L. Wahl, S. Ariyan, and D. N. Hebert. Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway. J. Biol. Chem. 277:14821-14828, 2002.
54. Haldane, J. B. S., A. D. Sprunt, and N. M. Haldane. Reduplication in mice. J. Genet. 5:133-135, 1915.
55. Hamabe, J.-I., Y. Fukushima, N. Harada, K. Abe, N. Matsuo, T. Nagai, A. Yoshioka, H. Tonoki, R. Tsukino, and N. Niikawa. Molecular study of the Prader-Willi syndrome: deletion, RFLP, and phenotype analysis of 50 patients. Am. J. Med. Genet. 41:54-63, 1991.
56. Harada, M., and P. F. Robbins. AF172849 GenBank Direct Submission, 27 July 1999.
57. Harada, M., Y. F. Li, M. El-Gamil, S. A. Rosenberg, and P. F. Robbins. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells. Cancer Res. 61:1089-1094, 2001.
58. Hearing, V. J., and K. Tsukamoto. Enzymatic control of pigmentation in mammals. FASEB J. 5:2902-2909, 1991.
59. Hearing, V. J., P. Phillips, and M. A. Lutzner. The fine structure of melanogenesis in coat-color mutants of the mouse. J. Ultrastruct. Res. 43:88-106, 1973.
60. Heim, R. A., D. S. Dunn, S. E. Candy, E. Zwane, J. G. Kromberg, and T. Jenkins. The tyrosinase-positive oculocutaneous albinism locus is not linked to the beta-globin locus in man. Hum. Genet. 79:89, 1988.
61. Hittner, H. M., R. A. King, V. M. Riccardi, D. H. Ledbetter, R. P. Borda, R. E. Ferrell, and F. L. Kretzer. Ocolocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-Willi syndrome. Am. J. Ophthalmol. 94:328-337, 1982.
62. Ikinciogullari, A., M. Tekin, F. Dogu, I. Reisli, G. Tanir, Z. Yi, N. Garrison, M. H. Brilliant, and E. Babacan. Meningococccal meningitis and complement component 6 deficiency associated with oculocutaneous albinism. Eur. J. Pediatr. 164:177-179, 2005.
63. Inagaki, K., T. Suzuki, H. Shimizu, N. Ishii, Y. Umezawa, J. Tada, N. Kikuchi, M. Takata, K. Takamori, M. Kishibe, M. Tanaka, Y. Miyamura, S. Ito, and Y. Tomita. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am. J. Hum. Genet. 74:466-471, 2004.
64. Isaac, E. L., L. E. Karageorgos, D. A. Brooks, J. J. Hopwood, and P. J. Meikle. Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage. Exp. Cell Res. 254:204-209, 2000.
65. Jeambrun, J., and B. Sergent. Les Enfants de la Lune. Paris: INSERM-ORSTOM, 1991.
66. Johnson, D. K., L. J. Stubbs, C. T. Culiat, C. S. Montgomery, L. B. Russell, and E. M. Rinchik. Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus. Genetics 141:1563-1571, 1995.
67. Katayama, H., T. Ota, K. Morita, Y. Terada, F. Suzuki, O. Katoh, and M. Tatsuka. Human AIM-1: cDNA cloning and reduced expression during endomitosis in megakaryocyte-lineage cells. Gene 224:1-7, 1998.
68. Kedda, M. A., G. Stevens, P. Manga, C. Viljoen, T. Jenkins, and M. Ramsay. The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids. Am. J. Hum. Genet. 54:1078-1084, 1994.
69. Kerr, R., G. Stevens, P. Manga, S. Salm, P. John, T. Haw, and M. Ramsay. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa. Hum. Mutat. 15:166-172, 2000.
70. King, R. A., G. L. Wiesner, D. Townsend, and J. G. White. Hypopig-mentation in Angelman syndrome. Am. J. Med. Genet. 46:40-44, 1993.
71. King, R. A., J. Pietsch, J. P. Fryer, S. Savage, M. J. Brott, I. Russell-Eggitt, C. G. Summers, and W. S. Oetting. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum. Genet. 113:502-513, 2003 a.
72. King, R. A., R. K. Willaert, R. M. Schmidt, J. Pietsch, S. Savage, M. J. Brott, J. P. Fryer, C. G. Summers, and W. S. Oetting. MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am. J. Hum. Genet. 73:638-645, 2003 b.
73. Knoll, J. H., J. Wagstaff, and M. Lalande. Cytogenetic and molecular studies in the Prader-Willi and Angelman syndromes: an overview. Am. J. Med. Genet. 46:2-6, 1993.
74. Lamoreux, M. L., B. K. Zhou, S. Rosemblat, and S. J. Orlow. The pinkeyed-dilution protein and the eumelanin/pheomelanin switch: in support of a unifying hypothesis. Pigment Cell Res. 8:263-270, 1995.
75. Lee, S.-T., R. D. Nicholls, S. Bundey, R. Laxova, M. Musarella, and R. A. Spritz. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N. Engl. J. Med. 330:529-534, 1994 a.
76. Lee, S. T., R. D. Nicholls, R. E. Schnur, L. C. Guida, J. Lu-Kuo, N. B. Spinner, E. H. Zackai, and R. A. Spritz. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2). Hum. Mol. Genet. 3:2047-2051, 1994 b.
77. Lee, S. T., R. D. Nicholls, M. T. Jong, K. Fukai, and R. A. Spritz. Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics 26:354-363, 1995.
78. Lehman, A. L., W. K. Silvers, N. Puri, K. Wakamatsu, S. Ito, and M. H. Brilliant. The underwhite (uw) locus acts autonomously and reduces the production of melanin via a unique pathway. J. Invest. Dermatol. 115:601-606, 2000.
79. Little, C. C. Coat-color genes in rodents and carnivores. Q. Rev. Biol. 33:103-137, 1958.
80. Lund, P. M., N. Puri, D. Durham-Pierre, R. A. King, and M. H. Brilliant. Oculocutaneous albinism in an isolated Tonga community in Zimbabwe. J. Med. Genet. 34:733-735, 1997.
81. Lyon, M. F., T. R. King, Y. Gondo, J. M. Gardner, Y. Nakatsu, E. M. Eicher, and M. H. Brilliant. Genetic and molecular analysis of recessive alleles at the pink-eyed dilution (p) locus of the mouse. Proc. Natl. Acad. Sci. USA 89:6968-6972, 1992.
82. Magenis, R. E., S. Toth-Fejel, L. J. Allen, M. Black, M. G. Brown, S. Budden, R. Cohen, J. M. Friedman, D. Kalousek, and J. Zonana. Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am. J. Med. Genet. 35:333-349, 1990.
83. Manga, P., and S. J. Orlow. The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2). J. Dermatol. 26:738-747, 1999.
84. Manga P., and S. J. Orlow. Inverse correlation between pink-eyed dilution protein expression and induction of melanogenesis by bafilomycin A1. Pigment Cell Res. 14:362-367, 2001.
85. Manga, P., J. Kromberg, A. Turner, T. Jenkins, and M. Ramsay. In Southern Africa, brown oculocutaneous albinism (BOCA) maps to the OCA2 locus on chromosome 15q: P-gene mutations identified. Am. J. Hum. Genet. 68:782-787, 2001.
86. Mariat, D., S. Taourit, and G. Guerin. A mutation in the MATP gene causes the cream coat colour in the horse. Genet. Sel. Evol. 35:119-133, 2003.
87. Markert, C. L., and W. K. Silvers. The effects of genotype and cell environment on melanoblast differentiation in the house mouse. Genetics 41:429-450, 1956.
88. Melvold, R. W. Spontaneous somatic reversion in mice. Effects of parental genotype on stability at the p-locus. Mutat. Res. 12:171-174, 1971.
89. Moellmann, G., A. Slominski, E. Kuklinska, and A. B. Lerner. Regulation of melanogenesis in melanocytes. Pigment Cell Res. 1:79-87, 1988.
90. Nakatsu, Y., R. F. Tyndale, T. M. DeLorey, D. Durham-Pierre, J. M. Gardner, H. J. McDanel, Q. Nguyen, J. Wagstaff, M. Lalande, J. M. Sikela, R. W. Olsen, A. J. Tobin, and M. H. Brilliant. A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus. Nature 364:448-450, 1993.
91. Nakayama, K., S. Fukamachi, H. Kimura, Y. Koda, A. Soemantri, and T. Ishida. Distinctive distribution of AIM1 polymorphism among major human populations with different skin color. J. Hum. Genet. 47:92-94, 2002.
92. Newton, J. M., O. Cohen-Barak, N. Hagiwara, J. M. Gardner, M. T. Davisson, R. A. King, and M. H. Brilliant. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. Am. J. Hum. Genet. 69:981-988, 2001.
93. Nicholls, R. D. Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review. Am. J. Med. Genet. 46:16-25, 1993.
94. Oakey, R. J., N. M. Keiper, A. S. Ching, and M. H. Brilliant. Molecular analysis of the cDNAs encoded by the pun and pJ alleles of the pink-eyed dilution locus. Mamm. Genome 7:315-316, 1996.
95. Oetting, W. S., and R. A. King. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum. Mutat. 13:99-115, 1999.
96. Oetting, W. S., J. M., Gardner, J. P. Fryer, A. Ching, D. Durham-Pierre, R. A. King, and M. H. Brilliant. Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online Hum. Mutat. 12:434, 1998.
97. Orlow, S. J. Melanosomes are specialized members of the lysosomal lineage of organelles. J. Invest. Dermatol. 105:3-7, 1995.
98. Pellegrino, J. E., R. E. Schnur, R. Kline, E. H. Zackai, and N. B. Spinner. Mosaic loss of 15q11q13 in a patient with hypomelanosis of Ito: is there a role for the P gene? Hum. Genet. 96:485-489, 1995.
99. Potterf, S. B., J. Muller, I. Bernardini, F. Tietze, T. Kobayashi, V. J. Hearing, and W. A. Gahl. Characterization of a melanosomal transport system in murine melanocytes mediating entry of the melanogenic substrate tyrosine. J. Biol. Chem. 271:4002-4008, 1996.
100. Potterf, S. B., M. Furumura, E. V. Sviderskaya, C. Santis, D. C. Bennett, and V. J. Hearing. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes. Exp. Cell Res. 244:319-326, 1998.
101. Puri, N., D. Durbam-Pierre, R. Aquaron, P. M. Lund, R. A. King, and M. H. Brilliant. Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene. Hum. Genet. 100:651-656, 1997.
102. Puri N., J. M. Gardner, and M. H. Brilliant. Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. J. Invest. Dermatol. 115:607-613, 2000.
103. Ramaiah, A. Lag kinetics of tyrosinase: its physiological implications. Ind. J. Biochem. Biophys. 33:349-356, 1996.
104. Ramsay, M., M.-A. Colman, G. Stevens, E. Zwane, J. Kromberg, M. Farrall, and T. Jenkins. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Am. J. Hum. Genet. 51:879-884, 1992.
105. Raposo, G., and M. S. Marks. The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis. Traffic 3:237-248, 2002.
106. Rebbeck, T. R., P. A. Kanetsky, A. H. Walker, R. Holmes, A. C. Halpern, L. M. Schuchter, D. E. Elder, and D. Guerry. P gene as an inherited biomarker of human eye color. Cancer Epidemiol. Biomarkers Prev. 11:782-784, 2002.
107. Rinchik, E. M., S. J. Bultman, B. Horsthemke, S.-T. Lee, K. M. Strunk, R. A. Spritz, K. M. Avidano, M. T. C. Jong, R. D. Nicholls. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 361:72-76, 1993.
108. Rosemblat, S., D. Durham-Pierre, J. M. Gardner, Y. Nakatsu, M. H. Brilliant, and S. J. Orlow. Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. Proc. Natl. Acad. Sci. USA 91:12071-12075, 1994.
109. Rosemblat, S., E. V. Sviderskaya, D. J. Easty, A. Wilson, B. S. Kwon, D. C. Bennett, and S. J. Orlow. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: correction by culture in the presence of excess tyrosine. Exp. Cell Res. 239:344-352, 1998.
110. Rundshagen, U., C. Zuhlke, S. Opitz, E. Schwinger, and B. Kasmann-Kellner. Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4. Hum. Mutat. 23:106-110, 2004.
111. Russell, E. S. A quantitative histological study of the pigment found in the coat-color mutants of the house mouse. III. Interdependence among the variable granule attributes. Genetics 34:133-145, 1949.
112. Russell, L. B., C. S. Montgomery, N. L. Cacheiro, and D. K. Johnson. Complementation analyses for 45 mutations encompassing the pink-eyed dilution (p) locus of the mouse. Genetics 141:1547-1562, 1995.
113. Saitoh, S., N. Harada, Y. Jinno, K. Hashimoto, K. Imaizumi, Y. Kuroki, Y. Fukushima, T. Sugimoto, M. Renedo, and J. Wagstaff. Molecular and clinical study of 61 Angelman syndrome patients. Am. J. Med. Genet. 52:158-163, 1994.
114. Schreiber, R., and D. Haussinger. Characterization of the swelling-induced alkalinization of endocytotic vesicles in fluorescein isothiocyanate-dextran-loaded rat hepatocytes. Biochem. J. 309: 19-24, 1995.
115. Schreiber, R., F. Zhang, and D. Haussinger. Regulation of vesicular pH in liver macrophages and parenchymal cells by ammonia and anisotonicity as assessed by fluorescein isothiocyanate-dextran fluorescence. Biochem. J. 315:385-392, 1996.
116. Shriver, M. D., E. J. Parra, S. Dios, C. Bonilla, H. Norton, C. Jovel, C. Pfaff, C. Jones, A. Massac, N. Cameron, A. Baron, T. Jackson, G. Argyropoulos, L. Jin, C. J. Hoggart, P. M. McKeigue, and R. A. Kittles. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum. Genet. 112:387-399, 2003.
117. Sidman, R. L., and R. Pearlstein. Pink-eyed dilution (p) gene in rodents, increased pigmentation in tissue culture. Dev. Biol. 12:93-116, 1965.
118. Smith, D. R., D. T. Spaulding, H. M. Glenn, and B. B. Fuller. The relationship between Na(+)/H(+) exchanger expression and tyrosinase activity in human melanocytes. Exp. Cell Res. 298:521-534, 2004.
119. Snell, G. D., and L. C. Stevens. Histocompatibility genes of mice, III. H-1 and H4, two histocompatibility loci in the first linkage group. Immunology 4:366-379, 1961.
120. Spritz, R. A., K. Fukai, S. A. Holmes, and J. Luande. Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2). Am. J. Hum. Genet. 5675: 1320-1323, 1995.
121. Spritz, R. A., T. Bailin, R. D. Nicholls, S. T. Lee, S. K. Park, M. J. Mascari, and M. G. Butler. Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplo-type of the hemizygous P allele. Am. J. Med. Genet. 71:57-62, 1997.
122. Stadler, R., E. Truernit, M. Gahrtz, and N. Sauer. The AtSUC1 sucrose carrier may represent the osmotic driving force for anther dehiscence and pollen tube growth in Arabidopsis. Plant J. 19:269-278, 1999.
123. Staleva, L., P. Manga, and S. J. Orlow. Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism. Mol. Biol Cell. 13:4206-4220, 2002.
124. Stephenson, D. A., and J. E. Hornby. Gene expression at the pinkeyed dilution (p) locus in the mouse is confirmed to be pigment cell autonomous using recombinant embryonic skin grafts. J. Embryol. Exp. Morphol. 87:65-73, 1985.
125. Stevens, G., J. van Beukering, T. Jenkins, and M. Ramsay. An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids. Am. J. Hum. Genet. 56:586-591, 1995.
126. Stevens, G., M. Ramsay, and T. Jenkins. Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb P gene deletion mutation. Hum. Genet. 99:523-527, 1997.
127. Sturm, R. A., and T. N. Frudakis. Eye colour: portals into pigmentation genes and ancestry. Trends Genet. 20:327-332, 2004.
128. Sturm, R. A., R. D. Teasdale, and N. F. Box. Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277: 49-62, 2001.
129. Sweet, H. O., M. H. Brilliant, S. A. Cook, K. R. Johnson, and M. T. Davisson. A new allelic series for the underwhite gene on mouse chromosome 15. J. Hered. 89:546-51, 1998.
130. Teichmann, U., M. E. Ray, J. Ellison, C. Graham, G. Wistow, P. S. Meltzer, J. M. Trent, and W. J. Pavan. Cloning and tissue expression of the mouse ortholog of AIM1, a betagamma-crystallin superfamily member. Mamm. Genome 9:715-720, 1998.
131. Tomita, Y., A. Takeda, S. Okinaga, H. Tagami, and S. Shibahara. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem. Biophys. Res. Commun. 164:990-996, 1989.
132. Toyofuku, K., J. C. Valencia, T. Kushimoto, G. E. Costin, V. M. Virador, W. D. Vieira, V. J. Ferrans, and V. J. Hearing. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res. 15:217-224, 2002.
133. Tripathi, R. K., C. Chaya-Devi, and A. Ramaiah. pH-dependent interconversion of two forms of tyrosinase in human skin. Biochem. J. 252:481-487, 1988.
134. Vijayasaradhi, S., Y. Xu, B. Bouchard, and A. N. Houghton. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75. J. Cell Biol. 130:807-820, 1995.
135. Wallis, C. E., and P. H. Beighton. Synchrony of oculocutaneous albinism, the Prader-Willi syndrome, and a normal karyotope. J. Med. Genet. 26:337-339, 1989.
136. Watabe, H., J. C. Valencia, K. Yasumoto, T. Kushimoto, H. Ando, J. Muller, W. D. Vieira, M. Mizoguchi, E. Appella, and V. J. Hearing. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. J. Biol. Chem. 279:7971-7981, 2004.
137. Weisner, G. L., C. M. Bendel, D. P. Olds, J. G. White, D. C. Arthur, D. W. Ball, and R. A. King. Hypopigmentation in the Prader-Willi syndrome. Am. J. Hum. Genet. 40:431-442, 1987.
138. Witkop, C. J., Jr. Inherited disorders of pigmentation. Clin. Dermatol. 3:70-134, 1985.
139. Witkop, C. J., Jr., W. E. Nance, R. F. Rawls, and J. G. White. Autosomal recessive oculocutaneous albinism in man. Evidence for genetic heterogeneity. Am. J. Hum. Genet. 22:55-74, 1970.
140. Witkop, C. J., Jr., J. D. Niswander, D. R. Bergsma, P. L. Workman, and J. G. White. Tyrosinase positive oculocutaneous albinism among the Zuni and the Brandywine triracial isolate: biochemical and clinical characteristics and fertility. Am. J. Phys. Anthropol. 36:397-406, 1972.
141. Witkop, C. J., Jr., C. W. Hill, S. Desnick, J. K. Thies, H. L. Thorn, M. Jenkins, and J. G. White. Ophthalmologic, biochemical, platelet, and ultrastructural defects in the various types of oculocutaneous albinism. J. Invest. Dermatol. 60:443-456, 1973.
142. Woolf, C. M., and F. C. Dukepoo. Hopi indians, inbreeding, and albinism. Science 164:30-37, 1969.
143. Yi, Z., N. Garrison, O. Cohen-Barak, T. M. Karafet, R. A. King, R. P. Erickson, M. F. Hammer, and M. H. Brilliant. A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population. Am. J. Hum. Genet. 72:62-72, 2003.
144. Yuasa, I., K. Umetsu, G. Watanabe, H. Nakamura, M. Endoh, and Y. Irizawa. MATP polymorphisms in Germans and Japanese: the L374F mutation as a population marker for Caucasoids. Int. J. Legal Med. 118:364-366, 2004.
145. Zhu, G., D. M. Evans, D. L. Duffy, G. W. Montgomery, S. E. Medland, N. A. Gillespie, K. R. Ewen, M. Jewell, Y. W. Liew, N. K. Hayward, R. A. Sturm, J. M. Trent, and N. G. Martin. A genome scan for eye color in 502 twin families: most variation is due to a QTL on chromosome 15q. Twin Res. 7:197-210, 2004.